ABCB6, ABCB1 and ABCG1 genetic polymorphisms and antidepressant response of SSRIs in Chinese depressive patients. (Q48404747)

11 February 2018

title

ABCB6, ABCB1 and ABCG1 genetic polymorphisms and antidepressant response of SSRIs in Chinese depressive patients. (English)

1 reference

11 February 2018

author name string

Xiaoye Huang

1

1 reference

11 February 2018

Tao Yu

2

1 reference

11 February 2018

Xin Li

3

1 reference

11 February 2018

Yanfei Cao

4

1 reference

11 February 2018

Xingwang Li

5

1 reference

11 February 2018

Baocheng Liu

6

1 reference

11 February 2018

Fengping Yang

7

1 reference

11 February 2018

Weidong Li

8

1 reference

11 February 2018

Xinzhi Zhao

9

1 reference

11 February 2018

Guoyin Feng

10

1 reference

11 February 2018

Xu Zhang

11

1 reference

11 February 2018

Zaiquan Dong

12

1 reference

11 February 2018

Lin He

13

1 reference

11 February 2018

Xueli Sun

14

1 reference

11 February 2018

Guang He

15

1 reference

11 February 2018

publication date

1 November 2013

1 reference

11 February 2018

published in

Pharmacogenomics

1 reference

11 February 2018

volume

14

1 reference

11 February 2018

issue

14

1 reference

11 February 2018

page(s)

1723-1730

1 reference

11 February 2018

Advances in depression research: 2011.

cites work

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Depression and the workplace: a progress report

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Metabolic Issues With Atypical Antipsychotics in Primary Care: Dispelling the Myths

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Bursts and the efficacy of selective serotonin reuptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Pharmacogenetics in the treatment of depression: pharmacodynamic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Expression of caveolin-1 in human brain microvessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Case-control association study of 36 single-nucleotide polymorphisms within 10 candidate genes for major depression and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

The role of ABC transporters in progression and clinical outcome of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET microarray profiling study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

The human ATP-binding cassette (ABC) transporter superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Purification and reconstitution of human P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Emerging new technologies in Pharmacogenomics: rapid SNP detection, molecular dynamic simulation, and QSAR analysis methods to validate clinically important genetic variants of human ABC Transporter ABCB1 (P-gp/MDR1).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

The genetic polymorphism of drug transporters: functional analysis approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

The ATP-binding cassette transporter ABCB6 is induced by arsenic and protects against arsenic cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Evaluation of the role of P-glycoprotein in the uptake of paroxetine, clozapine, phenytoin and carbamazapine by bovine retinal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Effects of sertraline and fluoxetine on p-glycoprotein at barrier sites: in vivo and in vitro approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.151

21 January 2018

Identifiers

DOI

10.2217/PGS.13.151

1 reference

11 February 2018

PubMed ID

24192121

1 reference

11 February 2018